Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI)-Reference-Cited by-同舟云学术

Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI)

Published:2018-11-29 Issue:1 Volume:10 Page:
ISSN:1758-9193
Container-title:Alzheimer's Research & Therapy
language:en
Short-container-title:Alz Res Therapy

Author:

de Rojas Itziar, ,Romero J.,Rodríguez-Gomez O.,Pesini P.,Sanabria A.,Pérez-Cordon A.,Abdelnour C.,Hernández I.,Rosende-Roca M.,Mauleón A.,Vargas L.,Alegret M.,Espinosa A.,Ortega G.,Gil S.,Guitart M.,Gailhajanet A.,Santos-Santos M. A.,Moreno-Grau Sonia,Sotolongo-Grau O.,Ruiz S.,Montrreal L.,Martín E.,Pelejà E.,Lomeña F.,Campos F.,Vivas A.,Gómez-Chiari M.,Tejero M. A.,Giménez J.,Pérez-Grijalba V.,Marquié G. M.,Monté-Rubio G.,Valero S.,Orellana A.,Tárraga L.,Sarasa M.,Ruiz A.^ORCID,Boada M.

Funder

GRIFOLS

ARACLON

PIRAMAL AG

Laboratorios ECHEVARNE

Publisher

Springer Science and Business Media LLC

Subject

Cognitive Neuroscience,Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1186/s13195-018-0444-1.pdf

Reference65 articles.

1. Izco M, et al. Changes in the brain and plasma Abeta peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer’s disease. Neuroscience. 2014. https://doi.org/10.1016/j.neuroscience.2014.01.003 .

2. Ballard C, et al. Alzheimer’s disease. Lancet. 2011;377:1019–31.

3. Ruiz A, et al. Blood amyloid beta levels in healthy, mild cognitive impairment and Alzheimer’s disease individuals: replication of diastolic blood pressure correlations and analysis of critical covariates. PLoS One. 2013. https://doi.org/10.1371/journal.pone.0081334 .

4. Soininen HS, Scbeltens P. Early diagnostic indices for the prevention of Alzheimer’s disease. Ann Med. 1998;30:553–9.

5. Monge-Argilés, J. A. et al. [Biomarkers in the cerebrospinal fluid of patients with mild cognitive impairment: a meta-analysis of their predictive capacity for the diagnosis of Alzheimer’s disease]. Rev Neurol 2010;50:193–200.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential neuropsychiatric associations of plasma biomarkers in older adults with major depression and subjective cognitive decline;Translational Psychiatry;2024-08-16

2. miR-519a-3p, found to regulate cellular prion protein during Alzheimer's disease pathogenesis, as a biomarker of asymptomatic stages;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-06

3. Longitudinal assessment of plasma biomarkers for early detection of cognitive changes in subjective cognitive decline;Frontiers in Aging Neuroscience;2024-05-17

4. Cognitive and immunological effects of yoga compared to memory training in older women at risk for alzheimer’s disease;Translational Psychiatry;2024-02-14

5. Performance of Plasma Biomarkers Combined with Structural MRI to Identify Candidate Participants for Alzheimer’s Disease-Modifying Therapy;The Journal of Prevention of Alzheimer's Disease;2024